LOINC Code 94222-7: SERPINA1 gene full mutation analysis Sequencing Doc (Bld/Tiss)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component SERPINA1 gene full mutation analysis. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Both
• Method: Sequencing

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• SERPINA1 gene full mutation analysis in Blood or Tissue by Sequencing
• SERPINA1 gene full mutation analysis
• Full gene sequence analysis to identify a mutation within the coding regions and intron/exon boundaries of the SERPINA1 gene. Testing is performed for the diagnosis of Alpha-1-antitrypsin (A1A), particularly when a low or deficient alpha-1-antitrypsin serum levels is not explained by routine testing.
• A1A; A1AT; AAT; Alpha-1-antitrypsin deficiency; alpha1AT; Anti-elastase gene; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PI; PI1; Point in time; PRO2275; Protease inhibitor 1; Random; sequencing of entire coding region; Serine (or cysteine) proteinase inhibitor; serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions